<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 1) *
APACHE MEDICAL SYSTEMS, INC.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $0.01 par value per share
--------------------------------------------------------------------------------
(Title of Class of Securities)
03746E 10 2
------------------------------
(CUSIP Number)
March 31, 2000
-------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[ ] Rule 13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
(Continued on following page(s))
Page 1 of 6 Pages
<PAGE>
CUSIP NO. 03746E 10 2 13G
------------------------------------------------------------------------------
NAMES OF REPORTING PERSONS.
1 I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
BAXTER HEALTHCARE CORPORATION
I.R.S. Identification Number: 36-2604143
BAXTER INTERNATIONAL INC
I.R.S. Identification Number: 36-0781620
------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
2 (a) [_]
(b) [_]
------------------------------------------------------------------------------
SEC USE ONLY
3
------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
4
DELAWARE
------------------------------------------------------------------------------
SOLE VOTING POWER
5
NUMBER OF 0
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 6
0
OWNED BY
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
7
REPORTING 0
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 8
0
------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9
0
------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
10 (SEE INSTRUCTIONS)
[_]
------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
11
0%
------------------------------------------------------------------------------
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
12
CO
------------------------------------------------------------------------------
Page 2 of 6 Pages
<PAGE>
CUSIP No. 03746E 10 2 13G
________________________________________________________________________________
This Schedule 13G reports a change in beneficial ownership. Baxter Healthcare
Corporation, a Delaware corporation ("Purchaser"), is no longer the holder of
573,346 shares (the "Shares") of common stock, $0.01 par value per share, of
Apache Medical Systems, Inc., a Delaware corporation.
On March 31, 2000, Baxter International Inc. parent of Purchaser, completed the
Spin-off of Edwards Lifesciences Corporation and its subsidiaries, formerly the
cardiovascular business. As a result of the Spin-off, all shares of Apache
Medical Systems, Inc. were transferred to Edwards Lifesciences LLC and no shares
are currently held by either of the Reporting Persons.
Item 1(a). Name of Issuer:
---------
Apache Medical Systems, Inc.
Item 1(b). Address of Issuer's Principal Executive Offices:
---------
1650 Tysons Boulevard
McLean, Virginia 22102
Item 2(a). Name of Person Filing:
----------
This statement is being filed by Purchaser and Baxter International
Inc., a Delaware corporation and the owner of 100% of the capital
stock of Purchaser ("Parent")
Item 2(b). Address of Principal Business Office or, if none, Residence:
---------
One Baxter Parkway
Deerfield, Illinois 60015
Item 2(c). Citizenship:
---------
Delaware
Item 2(d). Title of Class of Securities:
---------
Common stock, $0.01 par value per share of Apache Medical Systems,
Inc.
Item 2(e). CUSIP Number:
---------
03746E 10 2
Page 3 of 6 Pages
<PAGE>
CUSIP No. 03746E 10 2 13G
________________________________________________________________________________
Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or
------ (c) check whether filing person is a:
(a) [_] Broker or dealer registered under Section 15 of the Act
(b) [_] Bank as defined in Section 3(a)(6) of the Act
(c) [_] Insurance company as defined in Section 3(a)(19) of the Act
(d) [_] Investment company registered under Section 8 of the
Investment Company Act
(e) [_] An investment adviser in accordance with
Rule 13d-1(b)(1)(ii)(E)
(f) [_] An employee benefit plan or endowment fund in accordance with
Rule 13d-1(b)(1)(ii)(F)
(g) [_] A parent holding company or control person in accordance with
Rule 13d-1(b)(1)(ii)(G)
(h) [_] A savings association as defined in Section 3(b) of the
Federal Deposit Insurance Act (12 U.S.C. 1813)
(i) [_] A church plan that is excluded from the definition of an
investment company under Section 3(c)(14) of the Investment
Company Act of 1940 (15 U.S.C. 80a-3)
(j) [_] Group, in accordance with Rule 13d-1(b)(1)(ii)(J)
If this statement is filed pursuant to Rule 13d-1(c), check
this box: [X]
Item 4. Ownership
-------
This Schedule is being filed to report a change in beneficial
ownership.
(a) Amount Beneficially Owed: -0-
(b) Percent of Class: 0%
(c) Number of shares as to which the person has:
(i) sole power to vote or direct the vote: -0-
(ii) shared power to vote or direct the vote: -0-
(iii) sole power to dispose or to direct the
disposition of: -0-
(iv) shared power to dispose or to direct the
disposition of: -0-
Page 4 of 6 Pages
<PAGE>
CUSIP No. 03746E 10 2 13G
________________________________________________________________________________
Item 5. Ownership of Five Percent or Less of a Class:
------
If this Schedule is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of
more that five percent on the class of securities, check the following
box: [X]
Item 6. Ownership of More than Five Percent or Behalf of another Person:
------
Not Applicable
Item 7. Identification and Classification of the Subsidiary Which Acquired the
------- Security Being Reported on by the Parent Holding Company:
Not Applicable
Item 8. Identification and Classification of Members of the Group:
------
Not Applicable
Item 9. Notice of Dissolution of Group:
------
Not Applicable
Item 10. Certification:
-------
The Reporting Persons are no longer the beneficial owners of more than
five percent of the number of shares outstanding. The Reporting
Persons have no further reporting obligation under Section 13(d) of
the Securities and Exchange Commission, and the Reporting Persons have
no obligation to amend this Statement if any material change occurs in
the facts set forth herein.
Page 5 of 6 Pages
<PAGE>
CUSIP No. 03746E 10 2 13G
________________________________________________________________________________
S I G N A T U R E
After reasonable inquiry and to the best of my knowledge and belief, each of
Purchaser and Parent certifies that the information set forth in this statement
is true, complete and correct.
Date: July 21, 2000
Baxter International Inc.
By: /s/ Jan S. Reed
---------------
Jan S. Reed
Secretary
Baxter Healthcare Corporation
By: /s/ Jan S. Reed
---------------
Jan S. Reed
Secretary
Page 6 of 6 Pages
